SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

AstraZeneca Pharma India informs resignation of MD

24 Aug 2012 Evaluate
AstraZeneca Pharma India has informed that Anandh Balasundaram has resigned as managing director and member of the board with effect from the close of business hours on August 31, 2012. Accordingly, he shall cease to be managing director and member of the board of AstraZeneca Pharma India Limited with effect from the close of business hours on August 31, 2012. His resignation has been accepted by the board of directors on August 23, 2012.

Further, the company has, as an interim measure, appointed Jonathan Hunt as chief operating officer (COO) and President, for a period of four months commencing from September 01, 2012.

The above information is a part of company's filings submitted to BSE.

Astrazeneca Pharma Share Price

8445.35 38.75 (0.46%)
22-Jun-2026 11:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1851.95
Dr. Reddys Lab 1288.55
Cipla 1408.00
Zydus Lifesciences 1067.95
Lupin 2349.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: